Humana Inc.
Humana Inc. Reaffirms FY 2025 Earnings Guidance
Summary
On March 3, 2025, Humana Inc. announced via Regulation FD Disclosure that its senior management will meet with investors and analysts from March 3 to March 31, 2025, to reaffirm its guidance for diluted and adjusted earnings per share (EPS) for the fiscal year 2025. The guidance remains approximately $15.88 for diluted EPS and $16.25 for adjusted EPS, consistent with the guidance issued on February 11, 2025. Humana Inc. has included adjusted EPS, a non-GAAP financial measure, to provide a more comprehensive perspective on core operating performance.
Profitelligence Alerts
Get alerts for HUM
Be first to know when Humana Inc. files with the SEC.
Filing Categories
Advertisement
About Humana Inc.
Humana Inc. is a leading healthcare insurance company that primarily focuses on offering comprehensive health insurance products and services. It operates in the insurance sector and is a significant player in the Medicare Advantage market, providing coverage solutions for senior citizens eligible for Medicare. Additionally, Humana boasts a diverse range of health plans, including individual, group medical plans, and specialty products like dental and vision care. The company extends its services to various sectors, including government-sponsored healthcare programs and commercial employers, emphasizing wellness and preventive care. Humana’s offerings are designed to meet the needs of both individual consumers and large organizations, ensuring tailored healthcare coverage. Based in Louisville, Kentucky, Humana is a crucial component of the healthcare system in the United States, striving to improve health outcomes and provide affordable insurance options. The company continues to influence the healthcare industry by enhancing its digital solutions and fostering partnerships that promote integrated care between medical professionals and insurers.
Official SEC Documents
Advertisement